
|Articles|May 1, 2001
- Pharmaceutical Executive-05-01-2001
- Volume 0
- Issue 0
The Next Y2K
Author(s)Mark E. Kolb
Companies Face Costly System Overhauls With New FDA Regulations
Advertisement
Articles in this issue
over 24 years ago
Policy: Task Mastersover 24 years ago
Pharmacia's Carrie Cox: HBA Woman of the Yearover 24 years ago
Friends of Complexityover 24 years ago
Under Federal Fireover 24 years ago
Task Force: Enter the Fixersover 24 years ago
Political ScienceNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026: Moderna Planning Seasonal Respiratory Vaccine Franchise
2
JP Morgan 2026: Regeneron Focusing on Broad Pipeline Development
3
JP Morgan 2026: Merck’s De-risking of Future Funding
4
JP Morgan 2026: Bayer’s Rejuvenated Portfolio
5




